Abstract:
본 발명은 흰반점 증후군 바이러스(white spot syndrom virus; WSSV) 진단용 프라이머 세트, 올리고뉴클레오티드, 및 이를 포함하는 진단용 조성물, 진단용 키트 및 진단을 위한 정보 제공 방법에 관한 것이다. 본 발명에 따른 WSSV 외피막 단백질을 발현하는 유전자 VP19 또는 VP28과 결합하는 프라이머 세트 및 비특이반응 억제용 올리고뉴클레오티드를 이용하여 단일 튜브 이중 중합효소연쇄반응을 수행할 경우, WSSV에 대한 민감도를 개선시켜 1 카피수까지 검출가능하고, 진단 소요시간이 단축되며, 외부환경에 의한 오염을 차단하고, WSSV 검출률을 유의하게 증가시켜 WSSV를 특이적으로 검출할 수 있어, WSSV에 감염된 개체뿐만아니라, WSSV 매개체 및 보유 생물에서도 WSSV 검출이 가능하여 수생환경내 흰반점병의 감시, 전염병 조기 발견 및 통제를 위한 WSSV 유전자 진단에 유용하게 사용될 수 있다.
Abstract:
본 발명은 흰반점 증후군 바이러스(white spot syndrom virus; WSSV) 진단용 프라이머 세트, 올리고뉴클레오티드, 및 이를 포함하는 진단용 조성물, 진단용 키트 및 진단을 위한 정보 제공 방법에 관한 것이다. 본 발명에 따른 WSSV 외피막 단백질을 발현하는 유전자 VP19 또는 VP28과 결합하는 프라이머 세트 및 비특이반응 억제용 올리고뉴클레오티드를 이용하여 단일 튜브 이중 중합효소연쇄반응을 수행할 경우, WSSV에 대한 민감도를 개선시켜 1 카피수까지 검출가능하고, 진단 소요시간이 단축되며, 외부환경에 의한 오염을 차단하고, WSSV 검출률을 유의하게 증가시켜 WSSV를 특이적으로 검출할 수 있어, WSSV에 감염된 개체뿐만아니라, WSSV 매개체 및 보유 생물에서도 WSSV 검출이 가능하여 수생환경내 흰반점병의 감시, 전염병 조기 발견 및 통제를 위한 WSSV 유전자 진단에 유용하게 사용될 수 있다.
Abstract:
PURPOSE: A method for detecting Salmonella gallinarum or probiotics for Salmonella gallinarum vaccine is provided to quickly detect Salmonella gallinarum. CONSTITUTION: A method for detecting Salmonella gallinarum or probitocs Salmonella gallinarum comprises: a step of preparing DNA from a biological sample; a step of performing PCR using the DNA as a temperate and primer; and a step of analyzing DNA fragment through from PCR product.
Abstract:
A differential diagnostic method of duck hepatitis virus(DHV) type 1 is provided to improve rapidness and accuracy of diagnosis, and diagnose common genes and different genes of duck hepatitis virus type 1 in the liver tissue separated from young ducks infected by the duck hepatitis virus type 1, and viruses causing other RNA viral diseases derived from fowls. Duck hepatitis virus type 1 gene has the nucleotide sequence consisting of 2C gene, capsid gene and 5'-UTR(untranslated region) gene, wherein the 2C gene has the nucleotide sequence selected from SEQ ID NOs:1, 4, 7, 10, 13, 16, 19, 22 and 25; the capsid gene has the nucleotide sequence selected from SEQ ID NOs:2, 5, 8, 11, 14, 17, 20, 23 and 26; and the 5'-UTR gene has the nucleotide sequence selected from SEQ ID NOs:3, 6, 9, 12, 15, 18, 21, 24 and 27. Duck hepatitis virus-specific primers have the nucleotide sequences of SEQ ID NOs:28 to 33 and specifically recognize the 2C gene, capsid gene and 5'-UTR gene, respectively. A differential diagnostic method of duck hepatitis virus(DHV) type 1 comprises the steps of: (1) homogenizing the liver tissue separated from young ducks infected by the duck hepatitis virus type 1 to float in 10% PBS(phosphate buffered saline); (2) obtaining the supernatant and separating RNA from the supernatant by RNA extraction method; (3) synthesizing cDNA(complementary DNA) from the separated RNA through reverse transcription method by using reverse transcriptase; (4) preparing primers specific to 2C gene, capsid gene and 5'-UTR gene from cDNA, and amplifying the genes through PCR(polymerase chain reaction); and (5) subjecting the PCR products to electrophoresis using 1.5% agarose gel.
Abstract translation:提供1型鸭肝炎病毒(DHV)的鉴别诊断方法,以提高诊断的快速性和准确性,并在鸭肝炎病毒感染的幼鸭分离的肝组织中诊断1型鸭肝炎病毒的常见基因和不同基因 类型1,以及导致其他来源于家禽的RNA病毒病毒的病毒。 鸭肝炎病毒1型基因具有由2C基因,衣壳基因和5'-UTR(非翻译区)基因组成的核苷酸序列,其中2C基因具有选自SEQ ID NO:1,4,7,10, 13,16,19,22和25; 所述衣壳基因具有选自SEQ ID NO:2,5,8,11,14,17,20,23和26的核苷酸序列; 并且5'-UTR基因具有选自SEQ ID NO:3,6,9,12,15,18,21,24和27的核苷酸序列。鸭肝炎病毒特异性引物具有SEQ ID NO: 28〜33,分别特异性地识别2C基因,衣壳基因和5'-UTR基因。 鸭肝炎病毒(DHV)1型的鉴别诊断方法包括以下步骤:(1)将由1型鸭肝炎病毒感染的幼鸭分离的肝组织匀浆在10%PBS(磷酸盐缓冲盐水)中漂浮; (2)通过RNA提取方法获得上清液和上清液中的RNA; (3)使用逆转录酶通过逆转录法从分离的RNA合成cDNA(互补DNA); (4)从cDNA制备特异于2C基因,衣壳基因和5'-UTR基因的引物,并通过PCR(聚合酶链式反应)扩增基因; 和(5)使用1.5%琼脂糖凝胶对PCR产物进行电泳。
Abstract:
A method for diagnosing duck hepatitis virus type 1 is provided to reduce the diagnosis time, improve convenience of diagnosis, and enhance diagnosis accuracy by performing PCR using a primer set specific to duck hepatitis virus type 1. The method for diagnosing duck hepatitis virus type 1 comprises the steps of: (1) pulverizing the liver tissue infected by duck hepatitis virus and suspending the pulverized liver tissue in PBS(phosphate buffer saline); (2) extracting RNA from the supernatant by using LS reagent; (3) synthesizing cDNA from the extracted RNA by using reverse transcriptase(MMLV); (4) performing PCR using synthesized cDNA as a template using 3D gene-specific primers having the nucleotide sequences of SEQ ID NOs:6 and 7; and (5) subjecting the PCR product to electrophoresis by using 1.5% agarose gel, wherein the 3D gene is derived from duck hepatitis virus type 1 and has the nucleotide sequence selected from SEQ ID NO:1 to SEQ ID NO:5.
Abstract translation:提供一种用于诊断1型鸭肝炎病毒的方法,通过使用特异于1型鸭肝炎病毒的引物组进行PCR,减少诊断时间,提高诊断方便性,提高诊断准确度。1型鸭肝炎病毒诊断方法 包括以下步骤:(1)粉碎鸭肝炎病毒感染的肝组织,并将粉碎的肝组织悬浮于PBS(磷酸盐缓冲盐水)中; (2)使用LS试剂从上清液中提取RNA; (3)使用逆转录酶(MMLV)从提取的RNA合成cDNA; (4)使用具有SEQ ID NO:6和7的核苷酸序列的3D基因特异性引物,使用合成的cDNA作为模板进行PCR; 和(5)使用1.5%琼脂糖凝胶对PCR产物进行电泳,其中3D基因来源于1型鸭型肝炎病毒,并具有选自SEQ ID NO:1至SEQ ID NO:5的核苷酸序列。
Abstract:
A new vaccine to duck hepatitis virus is provided to have excellence in resistance against epidemic duck hepatitis and lessen damage caused by the duck hepatitis. A method for producing vaccine(deposition No. KCCM10883P) of duck hepatitis virus having sequence of sequence No. 1 [SEQ ID NO:1] comprises: a step of diluting recently epidemic duck hepatitis virus in phosphate buffer; a step of inoculating 7-9 days old chicken embryo; a step of culturing the inoculated chicken embryo at 37°C for three days; and a step of collecting the cultured chicken embryo and performing subculture sequencially to adapt the chicken embryo. A process for manufacturing a new vaccine is performed with: the step of attenuating the duck hepatitis virus; a step of testing restoration of attenuated virus; a step of searching defense ability of vaccine to selected duck hepatitis virus; a step of searching defense ability in each pathway; a step of searching minimum amount of the vaccine; and a step of safety and amount of the vaccine.
Abstract:
A riemerella vaccine for preventing riemerella infection is provided to defend the infection of field pathogenic Riemerella anatipestifer which occurs frequently in a country and prevent ducks from being perished by the riemerella infection, thereby minimizing economical loss of a duck industry. A riemerella vaccine for preventing riemerella infection comprises an inactivated Riemerella anatipestifer and an immuno-enhancing agent, wherein the inactivated Riemerella anatipestifer is a strain selected from the group consisting of serovar type I, serovar type IV, serovar type VII, serovar type XVI and a mixture strain thereof. A method for preparing the riemerella vaccine comprises the steps of: (a) culturing Riemerella anatipestifer isolated from a suck; (b) adding an inactivating agent such as 0.3% formalized physiological saline solution(FPSS) to a culture solution obtained from the step(a) to inactivate the Riemerella anatipestifer; and (c) adding an immuno-enhancing agent to the inactivated Riemerella anatipestifer culture solution to prepare a mixture vaccine. Further, the immuno-enhancing agent is ISA70.